Thursday, 8 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Get Alerts

Anthem Biosciences Ltd

NSE: ANTHEM · BSE: 544449 · Pharmaceuticals & Biotechnology · 31 announcements

Share price
₹887.05
Market cap
₹49,958 Cr
Revenue (annual)
₹2,124 Cr
Net profit (annual)
₹591.8 Cr
P/E (TTM)
86.7×Sector 47.3×
Promoter holding
71.42%-3.26% QoQ
FII holding
2.57%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 6Other Announcement 3Financial Results 3Results Update 2Business Update 2Board Meeting Outcome 2Board Meeting Date 2Annual Report 2Annual General Meeting 2Results Correction 1Management Change 1Legal & Regulatory 1Employee Stock Options 1Dividend 1Debt & Borrowing 1Credit Rating 1

Time

All time Last 1 weekLast 1 monthLast 2 monthsLast 3 monthsLast 6 monthsLast 1 year

2 announcements with these filters

20:13 IST NSE
Board Meeting Outcome

Anthem Biosciences Board Meeting Outcome

Anthem Biosciences board approved re-appointing Whole Time Director K Ravindra Chandrappa. Independent Director Ravikant Uppal continues beyond age 75, ensuring leadership continuity.

Read the filing ↗
17:18 IST BSE
Board Meeting Outcome

Anthem Biosciences Board Meeting Outcome

Anthem Biosciences approved the appointment of M/s. S. R. Batliboi & Associates LLP as Statutory Auditors for five years. The Board also approved an upside sharing arrangement involving a payment of ₹127.68 Crore to Promoters following an investor's divestment of 20,313,795 shares for ₹1,317 Crore.

Value
₹127.7 Cr
Read the filing ↗